Michael B. Foote

2.2k total citations · 1 hit paper
42 papers, 656 citations indexed

About

Michael B. Foote is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Michael B. Foote has authored 42 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Cancer Research and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Michael B. Foote's work include Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (6 papers) and RNA Interference and Gene Delivery (4 papers). Michael B. Foote is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (6 papers) and RNA Interference and Gene Delivery (4 papers). Michael B. Foote collaborates with scholars based in United States, Spain and Italy. Michael B. Foote's co-authors include Sang Kyoon Kim, Leaf Huang, Luis A. Díaz, Nickolas Papadopoulos, Melissa S. Pessin, Justin Jee, Yelena Y. Janjigian, Viswatej Avutu, Rimma Belenkaya and Melissa Lumish and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Michael B. Foote

32 papers receiving 651 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhancing immunotherapy with tumour-responsive nanomaterials

2025 39 citations Michael B. Foote et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael B. Foote United States	13	232	207	137	111	101	42	656
Han Han China	14	246 1.1×	175 0.8×	73 0.5×	90 0.8×	72 0.7×	46	648
Devon Evans United States	14	244 1.1×	157 0.8×	66 0.5×	52 0.5×	98 1.0×	34	729
Brian J. Rybarczyk United States	10	152 0.7×	152 0.7×	44 0.3×	57 0.5×	34 0.3×	18	743
Paul Miller United States	9	260 1.1×	119 0.6×	133 1.0×	60 0.5×	161 1.6×	20	829
Thomas S.C. Ng United States	18	118 0.5×	245 1.2×	157 1.1×	241 2.2×	26 0.3×	52	1.1k
Dominic Moore United States	16	437 1.9×	372 1.8×	27 0.2×	94 0.8×	100 1.0×	46	1.2k
Serena Perna Italy	17	523 2.3×	233 1.1×	48 0.4×	194 1.7×	45 0.4×	49	1.1k
James Thommes United States	13	390 1.7×	157 0.8×	210 1.5×	139 1.3×	162 1.6×	32	1.0k
Caroline Hoffmann France	19	164 0.7×	229 1.1×	47 0.3×	128 1.2×	55 0.5×	66	1.2k
Katelyn M. Atkins United States	19	207 0.9×	198 1.0×	75 0.5×	35 0.3×	85 0.8×	78	1.3k

Countries citing papers authored by Michael B. Foote

Since Specialization

Citations

This map shows the geographic impact of Michael B. Foote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Foote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Foote more than expected).

Fields of papers citing papers by Michael B. Foote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael B. Foote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Foote. The network helps show where Michael B. Foote may publish in the future.

Co-authorship network of co-authors of Michael B. Foote

This figure shows the co-authorship network connecting the top 25 collaborators of Michael B. Foote. A scholar is included among the top collaborators of Michael B. Foote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael B. Foote. Michael B. Foote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paty, Philip B., Martin R. Weiser, Michael B. Foote, et al.. (2026). Incidence and Predictors of Neoplastic Diagnosis in Patients with a Clinically Abnormal Appendix. Annals of Surgical Oncology.

Johannet, Paul, M. Herman Chui, Jason Konner, et al.. (2025). Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate. Gynecologic Oncology. 195. 173–179.

Artz, Oliver, Peter Ntiamoah, Caroline Weipert, et al.. (2025). Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 32(6). 1100–1109. 1 indexed citations

Foote, Michael B., Jingjing Li, Daniel Shao-Weng Tan, et al.. (2025). 925MO First-in-human phase I/Ib study of the oral Werner (WRN) helicase inhibitor HRO761 in patients (pts) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors: Interim safety and efficacy analysis from HRO761 single agent dose escalation. Annals of Oncology. 36. S567–S568.

Sweeney, Kieran, Paul Johannet, Oliver Artz, et al.. (2025). 111O The mechanism of mismatch repair deficiency (MMRd) informs survival outcomes derived from immune checkpoint blockade (ICB) across MMRd solid tumors. Annals of Oncology. 36. S237–S238.

Johannet, Paul, Henry Walch, Benoı̂t Rousseau, et al.. (2024). Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors. Journal of Clinical Oncology. 42(32). 3847–3857. 5 indexed citations

Foote, Michael B., James R. White, Walid K. Chatila, et al.. (2024). Analysis of Shared Variants between Cancer Biospecimens. Clinical Cancer Research. 31(2). 376–386.

Gui, Chengcheng, Henry Walch, Ahmet Turan Ilıca, et al.. (2024). Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases. Journal of neurosurgery. 142(2). 1–11.

Foote, Michael B., Henry Walch, Yelena Kemel, et al.. (2023). The Impact of Germline Alterations in Appendiceal Adenocarcinoma. Clinical Cancer Research. 29(14). 2631–2637. 2 indexed citations

10.

Marmarelis, Melina E., Xiao Wang, Leonid Roshkovan, et al.. (2023). Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma. JAMA Network Open. 6(3). e232526–e232526. 7 indexed citations

11.

Foote, Michael B., Guillem Argilés, Benoı̂t Rousseau, & Neil H. Segal. (2023). Facts and Hopes in Colorectal Cancer Immunotherapy. Clinical Cancer Research. 29(20). 4032–4039. 5 indexed citations

12.

Kudelka, Matthew R., Ghassan K. Abou‐Alfa, Eileen M. O’Reilly, et al.. (2023). Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report. Journal of Gastrointestinal Oncology. 14(4). 1878–1886. 1 indexed citations

13.

Jee, Justin, Michael B. Foote, Melissa Lumish, et al.. (2020). Chemotherapy and COVID-19 Outcomes in Patients With Cancer. Journal of Clinical Oncology. 38(30). 3538–3546. 173 indexed citations

14.

Foote, Michael B., Nickolas Papadopoulos, & Luis A. Díaz. (2015). Genetic Classification of Gliomas: Refining Histopathology. Cancer Cell. 28(1). 9–11. 32 indexed citations

15.

Tian, Xi, Kyle Wagner, Michael B. Foote, et al.. (2015). Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery. Nanoscale. 7(47). 20211–20219. 36 indexed citations

16.

Jazieh, Khalid, Michael B. Foote, & Luis A. Díaz. (2014). The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma. Seminars in Radiation Oncology. 24(2). 67–76. 13 indexed citations

17.

Kim, Sang Kyoon, Michael B. Foote, & Leaf Huang. (2012). Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles. Cancer Letters. 334(2). 311–318. 61 indexed citations

18.

Crawford, S W, et al.. (2012). Kidney Paired Donation: A Payer Perspective. American Journal of Transplantation. 12(6). 1388–1391. 23 indexed citations

19.

Kim, Sang Kyoon, Michael B. Foote, & Leaf Huang. (2012). The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles. Biomaterials. 33(15). 3959–3966. 123 indexed citations

20.

Sidhom, Mark, Michael B. Foote, Elizabeth Burmeister, et al.. (2008). Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: A clinican’s guide. Journal of Medical Imaging and Radiation Oncology. 52(5). 491–496. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact